|
Study | Study design | Country | Treatment | No. of patients | Gender (M/F) | Age | Follow-up | Duration |
Intervention | Control | Intervention | Control | Intervention | Control | Intervention | Control |
|
Kaderli 2007 [21] | Retrospective cohort study | Turkey | Triamcinolone intravitreal injection of 4 mg/0.1 mL | No treatment | 4 | 6 | 2/2 | 3/3 | 56-74 | 56-74 | >9 months | June 2004 to January 2005 |
Hayreh 2008 [20] | Retrospective cohort study | US | Prednisone 80 mg daily for 2 weeks, and then tapered down to 70 mg for 5 days, 60 mg for 5 days, and then cutting down by 5 mg every 5 days | No treatment | 312 | 301 | 188/124 | 175/126 | | | 3 months | 1973 to 2000 |
Rebolleda 2012 | Retrospective cohort study | Spain | Prednisone 80 mg daily for 2 weeks, and then tapered down to 70 mg for 5 days, 60 mg for 5 days, and then cutting down by 5 mg every 5 days | No treatment | 10 | 27 | 7/3 | 14/13 | | | 6 months | September 2008 to September 2009 |
Kinori 2014 [22] | Retrospective cohort study | Israel | Methylprednisolone (1 g/day) for 3 days, followed by oral prednisone (1 mg/kg) for 11 days | No treatment | 24 | 24 | 14/10 | 16/8 | | | 6 months | — |
Radoi 2014 [25] | Retrospective cohort study | France | Triamcinolone intravitreal injection of 4 mg/0.1 mL | No treatment | 21 | 15 | NR | NR | 59-91 | 59-91 | 6 months | February 2009 to November 2012 |
Pakravan 2016 [23] | Randomized controlled trial | Iran | Methylprednisolone 500 mg twice a day for 3 days, followed by 2 weeks of oral prednisolone 1 mg/kg/day | Placebo | 30 | 30 | 20/7 | 21/9 | | | 6 months | December 2010 to November 2013 |
Pakravan 2017 [24] | Prospective cohort study | Iran | Methylprednisolone 500 mg twice a day for 3 days followed with oral prednisolone 1 mg/kg for 10 days | Suggested treatments | 43 | 30 | 32/11 | 21/9 | | | 6 months | May 2012 to October 2015 |
Saxena 2018 [27] | Randomized controlled trial | India | Prednisone 80 mg daily for 2 weeks, and then tapered down to 70 mg for 5 days, 60 mg for 5 days, and then cutting down by 5 mg every 5 days | Placebo | 19 | 19 | 13/6 | 11/8 | | | 6 months | March 2015 to August 2016 |
Durbant 2021 [19] | Retrospective cohort study | France | Triamcinolone intravitreal injection of 4 mg/0.1 mL | No treatment | 41 | 27 | — | — | 66 | 68 | 6 months | 2009 to 2017 |
|